Worcester, MA, United States of America

Timothy A Riley

This inventor holds 43 USPTO granted patents and 12 published patent applications, plus 2 CIPO patents and 7 EPO patents, primarily in Oligomer Conjugates. Top assignees: Nektar Therapeutics, Genta Incorporated, Chimerix, Inc.. Active years: 1998-2023.

USPTO Granted Patents = 43 

% Patents Active = 86.0


 

Average Co-Inventor Count = 3.2

ph-index = 9

Forward Citations = 281(Granted Patents)


Location History:

  • Grover City, CA (US) (1998)
  • Nipomo, CA (US) (1998 - 2000)
  • Madison, WI (US) (2002)
  • Raleigh, NC (US) (2010)
  • Hunstville, AL (US) (2014)
  • Huntsville, AL (US) (2011 - 2016)
  • Alameda, CA (US) (2013 - 2017)
  • Worcester, MA (US) (2016 - 2023)

Company Filing History:


Years Active: 1998-2023

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Oligomer Conjugates
Polymeric Prodrugs
Protease Inhibitors
Opioid Agonists
Nucleoside Phosphates
Chirally Pure Phosphonates
Antiviral Phosphonates
Analgesic Compositions
Small-Interfering Nucleic Acids
Complexes
Dosage Forms
Enhanced Features
43 patents (USPTO):Explore Patents

Title: **Timothy A. Riley: Innovator in Polymeric Drug Conjugates**

Introduction

Timothy A. Riley, based in Worcester, MA, is a prominent inventor renowned for his contributions to the fields of drug development and polymer chemistry. With an impressive portfolio of 35 patents, he has been pivotal in creating innovative pharmaceutical solutions that enhance patient care through improved drug formulations.

Latest Patents

Among his notable patents, Riley's work on "Multi-arm polymeric prodrug conjugates of taxane-based compounds" stands out. This patent outlines methods for synthesizing polymeric conjugates that enable the controlled release of taxane-based compounds upon administration, thereby improving their therapeutic efficacy. Another significant innovation is related to "Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine," which details unique compounds exhibiting distinct effects compared to existing phenyltriazines, opening new avenues for therapeutics.

Career Highlights

Throughout his career, Riley has significantly advanced the pharmaceutical industry through his innovative approaches. He has held key positions in reputable companies such as Nektar Therapeutics and Chimerix, Inc., where he has contributed to the development of cutting-edge drug delivery systems and formulations.

Collaborations

Riley has collaborated with esteemed colleagues including Jennifer A. Riggs-Sauthier and Bo-Liang Deng. These partnerships have fostered a creative environment that promotes the exchange of ideas and knowledge, facilitating the growth of groundbreaking technologies in drug development.

Conclusion

Timothy A. Riley's steadfast dedication to innovation in pharmaceutical sciences through his extensive patent portfolio and collaborative efforts showcases his pivotal role in advancing modern medicine. His inventions not only reflect his expertise as an inventor but also his commitment to improving health outcomes for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…